1^st session

2^nd session

3^rd session

4^th session

All sessions

1^st session

Comparison of Antiplatelet Therapies for Prevention of Patent foramen ovale-associated stroke

cryptogenic stroke and high risk patent foramen ovale (DEFENCE-PFO trial)

european position paper on the management of patients with patent foramen ovale

Long-Term Outcomes of Patent Foramen ovale closure or medical therapy after stroke (RESPECT trial)

Management of the patient with patent foramen ovale in 2021 A spectrum of cases

Patent Foramen Ovale Closure for Stroke Prevention and Other

Patent Foramen Ovale Closure or Anticoagulation versus antiplatelets after stroke (CLOSE trial)

Patent Foramen Ovale Closure or antiplatelet therapy for cryptogenic stroke (REDUCE trial)

Percutaneous Closure of Patent ForamenOvale in Patients With MigraineThe PREMIUM Trial

Practice advisory update summary, Patent foramen ovale and secondary stroke prevention American Academy of Neurology

Treatment of patent foramen ovale (PFO) for secondary stroke prevention

Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA

2^nd session

beneficial effect of carotid endarterectomy in symptomtatic patients with high-grade carotid stenosis (NASCET trial)

Carotid artery stenosis – Current evidence and treatment recommendations

Carotid Artery Stenting Versus Endarterectomy for Treatment of Carotid Artery Stenosis

Complicated Carotid Artery Plaques as a cause of cryptogenic stroke (CAPIAS study)

Endarterectomy for Asymptomatic carotid artery stenosis (ACAS trial)

European Stroke Organisation guideline on endarterectomy and stenting for

Management of carotid stenosis for primary and secondary prevention of stroke, state-of-the-art 2020, a critical review

screening for asymptomatic carotid artery stenosis

Second asymptomatic carotid surgery trial (ACST-2)

Evaluation of carotid artery stenosis

Management of asymptomatic extracranial carotid atherosclerotic disease

Management of symptomatic carotid atherosclerotic disease

Screening for asymptomatic carotid artery stenosis

3^rd session

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fi

Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP), a multicentre, parallel group, unmasked, randomised controlled trial

Effectiveness of screening for atrial fibrillation and its determinants. A meta analysis

Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study), a randomized controlled trial

Opportunistic screening versus usual care for detection of atrial fibrillation in primary care cluster randomised controlled trial

Screening strategies for atrial fibrillation a systematic review and cost-effectiveness analysis

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over cluster randomised controlled trial

Subclinical Atrial Fibrillation and the Risk of Stroke (ASSERT trial)

Subclinical Atrial Fibrillation in Older patients (ASSERT II)

4^th session

Cilostazol for prevention of secondary stroke (CSPS 2) an aspirin-controlled, double-blind, randomised non-inferiority trial

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation, Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial

Rivaroxaban for Stroke Prevention after embolic stroke of undetermined source

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer, a subgroup analysis of the NAVIGATE ESUS randomized trial

Ticagrelor and Aspirin or Aspirin Alone in Acute ischemic stroke or TIA

All session

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline From the American Heart Association and American Stroke Association

Guidelines for the Early Management of Patients With Acute Ischemic Stroke 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association American Stroke Association

Prevention of Stroke in Patients With Silent Cerebrovascular Disease A Scientific Statement for Healthcare Professionals From the American Heart Association American Stroke Association

Primary Care of Adult Patients After Stroke A Scientific Statement From the American Heart Association American Stroke Association